1,531 results on '"Miyajima, Akira"'
Search Results
202. Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies
203. Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
204. Umbilical closure using 2‐octyl cyanoacrylate in transumbilical laparoscopic adrenalectomy: A randomized controlled trial
205. MP42-20 CLINICAL PREDICTORS FOR DETECTION OF SIGNIFICANT CANCER IN FOLLOW-UP BIOPSY AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: A MULTI-INSTITUTIONAL STUDY
206. MP42-12 PREDICTIVE VALUE OF LIQUID BIOPSY OF SERUM PSA-GLYCOSYLATION ISOMER FOR PATHOLOGICAL CHARACTERISTICS OF LOCALIZED INDEX PROSTATE CANCERS: A MULTI-INSTITUTIONAL STUDY
207. MP42-07 USEFULNESS OF COMPUTER-AIDED DIAGNOSIS SYSTEM IN EVALUATING SEVERITY OF BENIGN PROSTATIC HYPERPLASIA, USING A SUPER-ELLIPSE MODEL TO CHARACTERIZE CHANGES IN PROSTATE CONTOURS
208. Two cases of oligometastatic castration‐resistant prostate cancer detected by diffusion‐weighted whole‐body imaging with background body signal suppression
209. Brain metastasis of a papillary renal cell carcinoma, identified as type 2
210. Contrast-enhanced Ultrasonography of the Prostate with Sonazoid
211. D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the NADH Dehydrogenase Subunit 1 Gene
212. The clinical significance of urine cytology after a radical cystectomy for urothelial cancer
213. Extraperitoneal Approach Induces Postoperative Inguinal Hernia Compared with Transperitoneal Approach after Laparoscopic Radical Prostatectomy
214. Role of Pelvic Lymph Node Dissection in Lymph Node-Negative Patients with Invasive Bladder Cancer
215. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer
216. Prognostic Stratification in Patients Who Received Hormonal Therapy for Prostate-specific Antigen Recurrence after Radical Prostatectomy
217. Ets-I and Hypoxia Inducible Factor-1α Inhibition by Angiotensin II Type-1 Receptor Blockade in Hormone-Refractory Prostate Cancer
218. CONSERVATIVE THERAPY FOR BCG FAILURE NON-MUSCLE INVASIVE BLADDER CANCER: FOR WHOM SHOULD CYSTECTOMY BE CONSIDERED?: 1465
219. LATE RECURRENCE AND PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCERS AFTER 5-YEAR TUMOR-FREE PERIODS: CAN EXISTING RISK STRATIFICATION PROVIDE ACCURATE ESTIMATES OF LATE RECURRENCE AND PROGRESSION?: 1357
220. THE IMPACT OF POSITIVE CORE DENSITY ON PREDICTION OF THE PRETREATMENT STAGE OF PROSTATE CANCER: 301
221. Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo
222. Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer
223. Are predictive models for cancer volume clinically useful in localized prostate cancer?
224. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer
225. OPTIMIZED URINARY PH IS NECESSARY FOR THE IMPROVEMENT OF ADJUVANT MMC INSTILLATION TREATMENT FOR TUMOR RECURRENCE OF NON-MUSCLE INVASIVE BLADDER TUMORS.: 1914
226. PROGNOSTIC SIGNIFICANCE OF SNAIL EXPRESSION IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (UUT-UC): 189
227. Preoperative Prognostic Nomogram (Probability Table) for Renal Cell Carcinoma Based on TNM Classification
228. Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer
229. The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer
230. LONG-TERM OUTCOME OF RECURRENCE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER: BCG INSTILLATION IS NOT SUFFICIENTLY EFFECTIVE FOR LOW RISK PATIENTS: 1788
231. ENHANCED CHEMOSENSITIVITY TO PACLITAXEL BY VITAMIN E SUCCINATE IN BLADDER CANCER: 1082
232. THE THERAPEUTIC EFFECTS OF THE HUMAN INTERLEUKIN-6 RECEPTOR ANTIBODY (TOCILIZUMAB) ON PROSTATE CANCER: 647
233. NUCLEAR EXPRESSION OF ARYL HYDROCARBON RECEPTOR PREDICTS DISEASE SPECIFIC SURVIVAL OF UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: 199
234. RENAL INTERSTITIAL FIBROSIS, TUBULAR APOPTOSIS, AND INFLAMMATORY RESPONSE ARE INHIBITED IN MICE LACKING THE ANGIOTENSINOGEN GENE AND SUBJECTED TO UNILATERAL URETERAL OBSTRUCTION: 43
235. Angiotensin II Type 1 Receptor Antagonist as An Angiogenic Inhibitor in Prostate Cancer
236. Robot-assisted radical prostatectomy in a patient with prostate cancer complicated by benign prostate hypertrophy with middle lobe hypertrophy.
237. Assessment of Long-Term Quality of Life Using the FACT-BL Questionnaire in Patients with an Ileal Conduit, Continent Reservoir, or Orthotopic Neobladder
238. Preoperative Nomograms for Predicting Stone-Free Rate After Extracorporeal Shock Wave Lithotripsy
239. Retroperitoneoscopic partial nephrectomy using radiofrequency ablation
240. Differential expression of activator protein-2 isoforms in renal cell carcinoma
241. SUPPRESSION OF LUNG METASTASIS OF RENAL CELL CARCINOMA BY THE INTRAMUSCULAR GENE TRANSFER OF A SOLUBLE FORM OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR I
242. ATORVASTATIN AMELIORATES RENAL TISSUE DAMAGE IN UNILATERAL URETERAL OBSTRUCTION
243. This title is unavailable for guests, please login to see more information.
244. Incidentally discovered giant renal arteriovenous malformation
245. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction
246. Novel Nuclear Factor κB Activation Inhibitor Prevents Inflammatory Injury in Unilateral Ureteral Obstruction
247. Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction
248. Transluminal vascular stent implantation for a patient with renovascular hypertension due to renal artery stenosis
249. Significant Impact of the Anterior Transition Zone Portion Treatment on Urinary Function After Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer.
250. Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.